Skip to main content
MEDICLINIC INTERNATIONAL PLC logo

MEDICLINIC INTERNATIONAL PLC — Investor Relations & Filings

Ticker · MDC ISIN · US58471Q1004 LEI · 2138002S5BSBIZTD5I60 IL Human health and social work activities
Open in API
Filings indexed 628 across all filing types
Latest filing 2023-02-06 M&A Activity
Country GB United Kingdom
Listing IL MDC

About MEDICLINIC INTERNATIONAL PLC

https://www.mediclinic.com/en/home.html

Mediclinic International PLC is a diversified international private healthcare services group focused on providing specialist-orientated, multi-disciplinary services across the continuum of care. The company's clinical offerings include acute care, outpatient consultations, pre-hospital emergency services, day case surgery, and inpatient care. With a core purpose to enhance the quality of life, the group emphasizes delivering high-quality, patient-centric healthcare. Mediclinic operates with a sustainable, long-term approach, upholding high standards of clinical governance and investing in skilled professionals, advanced facilities, and modern medical equipment to be a trusted provider for clients, medical practitioners, and funders.

Recent filings

Filing Released Lang Actions
Form 8.3 - Mediclinic International plc
M&A Activity Classification · 1% confidence The document is explicitly titled 'FORM 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure/Dealing Disclosure made by a person holding 1% or more interest in relevant securities during a takeover situation. This type of disclosure relates to insider/significant shareholder activity during a takeover bid, which falls under the scope of M&A activity or specific regulatory filings related to takeovers. Since there is a specific category for M&A Activity (TAR), and this document details positions and dealings related to an offeror/offeree, TAR is the most appropriate classification, as it directly relates to a takeover/merger situation. It is not a general Director's Dealing (DIRS) as it is specifically tied to the Takeover Code rules during an offer period.
2023-02-06 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'FORM 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE'. Such disclosures are mandatory filings related to takeover activity, which falls under the scope of M&A activity or specific regulatory disclosures related to takeovers. Since the definitions provided do not have a specific code for 'Takeover Code Disclosure' (like Form 8.3), the closest relevant category is 'M&A Activity' (TAR), as this disclosure is directly triggered by a takeover situation involving Mediclinic International plc. Alternatively, it could be a general 'Regulatory Filing' (RNS), but TAR is more specific to the context of the content (Takeover Code). Given the content is a direct disclosure about interests/dealings during a potential takeover scenario, TAR is the most appropriate fit over the general RNS.
2023-02-03 English
Form 8.3 - Mediclinic International plc
M&A Activity Classification · 1% confidence The document is explicitly titled 'FORM 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure/Dealing Disclosure made by a person with interests representing 1% or more in relevant securities during a takeover situation. This type of disclosure relates directly to insider/significant shareholder activity during a takeover bid, which falls under the scope of M&A activity or specific regulatory filings related to takeovers. Since the definitions provided do not have a specific code for 'Takeover Disclosure Form 8.3', the closest relevant category that captures activity related to mergers/acquisitions is 'M&A Activity' (TAR), as this form is triggered by a takeover situation. However, given the highly specific nature of the form (insider dealing/position disclosure during a bid), it is a specialized regulatory filing. If 'TAR' (M&A Activity) is interpreted broadly to include all documents related to a takeover bid, it fits. If we must choose the most specific fit among the options, 'TAR' is the best fit because the context is explicitly a takeover bid ('Takeover Code'). Alternatively, 'RNS' (Regulatory Filings) is a fallback, but 'TAR' is more descriptive of the event triggering the filing.
2023-02-02 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled "FORM 8.3 - Mediclinic International plc" and references "Rule 8.3 of the Takeover Code (the “Code”)". Form 8.3 is a mandatory disclosure required under the UK Takeover Code when a person holding 1% or more of the relevant securities in a company subject to an offer makes a dealing or holds a position. This type of filing relates directly to insider transactions or major shareholder activity during a takeover scenario. This fits best under the category for Director's Dealing (DIRS) or potentially a specific regulatory filing, but given the context of insider/major shareholder activity during a potential M&A event (implied by the Takeover Code reference), it is a specific type of insider transaction disclosure. Since there is no specific code for 'Takeover Code Disclosure Form 8.3', and it details dealings/positions of a person with interests, it is most closely related to 'Director's Dealing' (DIRS) which covers personal share transactions by executives/insiders, or the general 'Regulatory Filings' (RNS). However, DIRS is specifically about insider trades. Given the context of a takeover and the nature of the disclosure (interests and dealings), it is a specialized insider/major shareholder disclosure. Since DIRS is defined as 'Report of personal share transactions by company directors and executives (insider trades)', and this is a disclosure of interests/dealings by a major shareholder during a potential takeover, DIRS is the most appropriate fit among the provided options for insider/executive transaction reporting, even though it's a specific regulatory form (Form 8.3). If DIRS is too narrow, RNS is the fallback. I will classify it as DIRS due to the focus on interests and dealings by a significant party in a corporate action context, which aligns with the spirit of insider reporting.
2023-02-01 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'FORM 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure/Dealing Disclosure by a person with interests in relevant securities representing 1% or more, which is a specific type of filing related to takeover activity. This directly relates to M&A Activity (TAR) or potentially a specific regulatory disclosure. Given the context of the Takeover Code and disclosure of interests during a potential offer scenario, the most appropriate category is M&A Activity (TAR), as this disclosure is triggered by a takeover situation. It is not a general Director's Dealing (DIRS) as it pertains to a specific takeover rule (Rule 8.3) and a major shareholder/stakeholder's position, rather than routine insider trading disclosure.
2023-01-31 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'FORM 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure/Dealing Disclosure made by a person holding 1% or more interest in relevant securities during a takeover situation. This type of disclosure relates to insider transactions or significant ownership changes during a takeover bid, which falls under the scope of insider dealing or major shareholding notifications related to M&A activity. Since the document details positions and dealings (including derivatives) related to an offeror/offeree, it is most closely related to insider trading disclosures during a takeover. Among the provided codes, 'Director's Dealing' (DIRS) covers personal share transactions by executives, and 'Major Shareholding Notification' (MRQ) covers changes in significant ownership. However, Form 8.3 is specifically mandated by the Takeover Code regarding parties to an offer. Given the context of a takeover ('offeror/offeree') and disclosure of interests/dealings by a major holder (Millennium International Management LP), this is a specific type of insider/major shareholder disclosure related to M&A. While 'DIRS' is for directors, this is for a major investor involved in a takeover. 'MRQ' is for general major shareholding changes, but Form 8.3 is highly specific to takeover rules. Since the document details personal dealings/positions of a major shareholder during a takeover process, it aligns best with the spirit of insider/director dealings or major shareholding notifications. Given the specific nature of the disclosure under the Takeover Code, and the fact that it details the holdings and dealings of a significant investor (Millennium International Management LP) in the context of an offer, it is a specialized form of insider/major shareholder disclosure. In the absence of a specific 'Takeover Disclosure' code, 'DIRS' (Director's Dealing) is the closest fit for reporting personal transactions/holdings by an interested party, although it is not strictly a director. Alternatively, 'MRQ' (Major Shareholding Notification) is also plausible. However, Form 8.3 is fundamentally about disclosure of interests during a takeover. Since the document details dealings and positions of a major shareholder (Millennium International Management LP) in relation to an offer for Mediclinic International plc, it is a specific type of insider transaction disclosure. I will classify it as 'DIRS' as it reports on the interests and dealings of a significant entity involved in the securities, which is the closest analogue to insider trading reports, even if the entity isn't a director. If 'TAR' (M&A Activity) were broader, it might fit, but 'DIRS' captures the 'dealing disclosure' aspect better than the general M&A code.
2023-01-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.